Imagin Medical Inc.

As of June 30, 2023, Imagin Medical Inc. has 10.83M shares outstanding.

These figures are as of June 30, 2023.

These figures are as of June 30, 2023. Imagin Medical Inc. trades at an EV/FCF ratio of 22.64, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2023, Imagin Medical Inc. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -92.23, indicating conservative leverage, while an interest coverage ratio of -328.52 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2023. Return on assets (ROA) is negative at -421.27, reflecting losses generated across the asset base. Return on capital employed (ROCE) is 1,269.37, useful for judging operating efficiency across full business cycles.

These figures cover the twelve months ended June 30, 2023. Free cash flow yield is negative at -15.31: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -103.63, meaning Imagin Medical Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Imagin Medical Inc.'s most recent stock split took place on October 27, 2020 with a 20:1 split ratio.

As of June 30, 2023, Imagin Medical Inc. has an Altman Z-Score of -470.13, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.